Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News

Icon

Trend: Pharma industry warming up to digital therapeutics

– Som­ryst app by Pear Ther­a­peu­tics

Dig­i­tal ther­a­peu­tics have poten­tial but com­mer­cial suc­cess unproven (Van­tage):

Devel­op­ing drugs to treat dis­or­ders of the cen­tral ner­vous sys­tem is famous­ly fraught with dif­fi­cul­ty. Sev­er­al com­pa­nies, includ­ing Pear Ther­a­peu­tics and Dthera, are tak­ing a wild­ly dif­fer­ent approach: dig­i­tal ther­a­peu­tics. These are pieces of soft­ware designed to treat dis­ease that are reg­u­lat­ed, pre­scribed and even paid for as if they were drugs … Pear is so far the only com­pa­ny to have brought a dig­i­tal ther­a­peu­tic to mar­ket – but it is by no means the only com­pa­ny in this space. Akili Inter­ac­tive has­filed for FDA approval of AKL-T01, a com­put­er game designed to treat ADHD, and Read the rest of this entry »

How to intervene early to address brain/ mental health problems: Examples in depression, epilepsy and smoking cessation

We hope you enjoy this slid­edeck sup­port­ing a fas­ci­nat­ing, for­ward-look­ing ses­sion held at the 2019 Sharp­Brains Vir­tu­al Sum­mit: The Future of Brain Health (March 7–9th).  Full record­ings are avail­able for pur­chase here.

10.45am-12.15pm. How to inter­vene ear­ly: Exam­ples in depres­sion, epilep­sy and smok­ing ces­sa­tion 

  • Dr. Wal­ter Green­leaf, Research Sci­en­tist at Stan­ford University’s Vir­tu­al Human Inter­ac­tion Lab
  • David B. Klein, CEO of Click Ther­a­peu­tics
  • Ana Maiques, CEO of Neu­ro­electrics
  • Chaired byAvery Bedows, Neu­rotech­nol­o­gy Spe­cial­ist at Loup Ven­tures

10+ pioneers confirmed to Speak @ 2019 SharpBrains Virtual Summit (May 7–9th)

_______________

We are proud to announce the first wave of con­firmed Speak­ers to share their inno­v­a­tive work and insights at the 2019 Sharp­Brains Vir­tu­al Sum­mit: The Future of Brain Health, to be held May 7–9th, 2019:

Dr. Tom Insel, Co-founder and Pres­i­dent of Mind­strong Health
Dr. Ainslie Hatch, Direc­tor of Dig­i­tal Ther­a­peu­tics at Otsu­ka Phar­ma­ceu­ti­cal
David Klein, CEO of Click Ther­a­peu­tics
Char­lie Hartwell, Oper­at­ing Part­ner at The Bridge Builders Col­lab­o­ra­tive
Louis Gagnon, CEO of Total Brain
Dr. Anna Wexler, sci­ence writer and PI of the Wexler Lab at UPenn
Dr. Eddie Mar­tuc­ci, Founder and CEO of Akili Inter­ac­tive Labs
Ana Maiques, CEO of Neu­ro­electrics
Jan Samzelius, Founder and CEO of Neu­raMetrix
Dr. Peter White­house, Pro­fes­sor of Neu­rol­o­gy at Case West­ern Reserve Uni­ver­si­ty
Kito Toset­ti, CEO of CTF MEG Inter­na­tion­al
Ariel Garten, Founder and Chief Evan­ge­lism Offi­cer of Inter­aX­on
Alvaro Fer­nan­dez, CEO and Edi­tor-in-Chief of Sharp­Brains

We can’t wait to discuss and help shape the Future of Brain Health!

_______________

Imag­ine your smart­phone can detect ear­ly signs of anx­i­ety, depres­sion or Parkinson’s Dis­ease — would you like to know? Who else should know … and not know?

Imag­ine a videogame cleared by the FDA to treat ADHD or sub­stance abuse — how will doc­tors pre­scribe it, patients access it, and insur­ers pay for it?

Imag­ine being respon­si­ble for the health & well­ness of your orga­ni­za­tion — how will you nav­i­gate the grow­ing toolk­it of evi­dence-based inter­ven­tions such as exercise/ meditation/ sleep apps/ cog­ni­tive therapies/ biofeedback/ tDCS?

Imag­ine invest­ing $100 mil­lion to help accel­er­ate brain research and appli­ca­tions — how would you ensure that respon­si­ble devel­op­ment meets wise adop­tion?

Imag­ine a free annu­al brain check-up — who should take it, and how could it help prevent/ delay/ treat cog­ni­tive decline and Alzheimer’s Dis­ease?

_______________

LEARN MORE HERE

Otsuka Pharma and Click Therapeutics enter partnership poised to transform mental healthcare

Otsu­ka, Click Ther­a­peu­tics part­ner to cre­ate ther­a­py for men­tal ill­ness (Ver­dict Med­ical Devices):

Otsu­ka Pharmaceutical’s US divi­sion Otsu­ka Amer­i­ca has part­nered with Click Ther­a­peu­tics to devel­op and com­mer­cialise a pre­scrip­tion dig­i­tal ther­a­peu­tic for treat­ing major depres­sive dis­or­der (MDD) Read the rest of this entry »

Sanofi Ventures leads $17M investment in Click Therapeutics, finalist @ 2017 Brainnovations Pitch Contest

___

Sanofi Backs Click Ther­a­peu­tics as Dig­i­tal Med­i­cines Gain Momen­tum (Xcon­o­my):

Drug mak­ers are mak­ing more bets on the nascent field of dig­i­tal med­i­cine. The lat­est exam­ple: Click Ther­a­peu­tics announced Mon­day that it grabbed a $17 mil­lion invest­ment led by Sanofi Ven­tures, the Cam­bridge, MA-based ven­ture cap­i­tal arm of the French phar­ma­ceu­ti­cal giant. Read the rest of this entry »

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters,  SharpBrains is an independent market research firm tracking how brain science can improve our health and our lives.

Search in our archives

Follow us and Engage via…

twitter_logo_header
RSS Feed

Watch All Recordings Now (40+ Speakers, 12+ Hours)

Enter Your Email to receive Sharp­Brains free, monthly eNewslet­ter:

Join more than 50,000 Sub­scribers and stay informed and engaged.